Table 9. Medicare ESRD program incidence per million population, by diagnosis and age: 1980.
Diagnosis | 0-14 years | 15-24 years | 25-34 years | 35-44 years | 45-54 years | 55-64 years | 65-74 years | 75 years and over |
---|---|---|---|---|---|---|---|---|
| ||||||||
Incidence per million | ||||||||
All causes | 7 | 24 | 58 | 86 | 136 | 204 | 241 | 153 |
Glomerulonephritis | 3 | 10 | 18 | 21 | 24 | 31 | 35 | 19 |
Primary hypertensive disease | 0 | 1 | 7 | 17 | 33 | 51 | 70 | 56 |
Diabetic nephropathy | ( 1) | 1 | 18 | 24 | 33 | 53 | 42 | 16 |
Polycystic kidney disease | ( 1) | ( 1) | 1 | 6 | 15 | 15 | 11 | 3 |
Collagen vascular disease | ( 1) | 1 | 1 | 2 | 2 | 1 | 2 | 1 |
Interstitial nephritis, hereditary | ( 1) | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Interstitial nephritis, other | ( 1) | 2 | 3 | 4 | 8 | 13 | 17 | 14 |
Analgesic abuse nephropathy | 0 | ( 1) | ( 1) | 1 | 2 | 3 | 3 | ( 1) |
Obstructive uropathy, acquired | ( 1) | ( 1) | ( 1) | ( 1) | 2 | 5 | 10 | 9 |
Obstructive uropathy, congenital | 1 | 2 | 1 | 1 | ( 1) | ( 1) | ( 1) | 0 |
Amyloidosis | 0 | 0 | 0 | ( 1) | 1 | 1 | 2 | 1 |
Multiple myeloma | 0 | 0 | 0 | ( 1) | 1 | 3 | 5 | 3 |
Gouty nephropathy | ( 1) | ( 1) | ( 1) | ( 1) | 1 | 1 | 1 | 1 |
Other, unspecified | 1 | 3 | 4 | 3 | 5 | 9 | 31 | 6 |
Etiology unknown | ( 1) | 2 | 3 | 6 | 10 | 16 | 11 | 22 |
Less than 1 per million.